| Triamcinolone-assisted 3D-vitrectomy in diabetic vitreomacular traction. | |
| | |
MedLine Citation:
|
PMID: 18797661 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To evaluate the efficacy of triamcinolone as an aid in vitreous visualization during 3D-vitrectomy for the treatment of diabetic vitreomacular traction. METHODS: Prospective interventional study in patients with symptomatic vitreomacular traction. Pre- and postoperative assessments included visual acuity, retinography, intraocular pressure and optical coherence tomography. All patients were operated by the same surgeon (OOMJ). Triamcinolone was used as a visual enhancer during surgery. The parameters of the vitreophage (Accurus 800CS, Alcon) were set to the 3D-system (dual dynamic drive), contact lenses (plain and wide angle) being used for visualization. Peripheral 360 masculine vitreous circumcision at high cut rate was performed, carefully releasing the vitreomacular adhesion at the posterior pole by means of an appropriate pic or vitreoretinal forceps. RESULTS: The sample consisted of five consecutive patients (five eyes), three female and two male, with symptomatic vitreomacular traction. Their age ranged from 54 to 71 years (mean 62.6 +/- 6.3 years). During the surgical procedure, the areas with vitreomacular traction were properly visualized and identified after the application of triamcinolone. No complications were recorded during or after surgery. There was a statistically significant improvement in visual acuity after the surgical procedure (p=0.0313). CONCLUSION: Triamcinolone facilitates the surgical treatment of vitreomacular traction by improving visibility of both the vitreous humor and the vitreous-retina interface. Triamcinolone-assisted 3D vitrectomy proved to be an effective procedure in these cases. |
| | |
Authors:
|
Otacilio de Oliveira Maia; Walter Yukihiko Takahashi; John Helal Júnior |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Arquivos brasileiros de oftalmologia Volume: 71 ISSN: 1678-2925 ISO Abbreviation: Arq Bras Oftalmol Publication Date: 2008 Jul-Aug |
Date Detail:
|
Created Date: 2008-09-17 Completed Date: 2009-06-25 Revised Date: 2009-07-27 |
Medline Journal Info:
|
Nlm Unique ID: 0400645 Medline TA: Arq Bras Oftalmol Country: Brazil |
Other Details:
|
Languages: eng Pagination: 518-22 Citation Subset: IM |
Affiliation:
|
Retina and Vitreous Service, University of São Paulo Medical School, São Paulo, SP, Brazil. omaiausp@uol.com.br |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Diabetic Retinopathy / surgery* Female Glucocorticoids / diagnostic use* Humans Intraoperative Care Macula Lutea / surgery* Male Middle Aged Postoperative Care Preoperative Care Prospective Studies Triamcinolone Acetonide / diagnostic use* Visual Acuity / physiology Vitrectomy / methods* Vitreous Body / pathology, surgery* |
| Chemical | |
Reg. No./Substance:
|
0/Glucocorticoids; 76-25-5/Triamcinolone Acetonide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Margin eyelid reconstruction with hard palate graft
Next Document: Learning effect of standard automated perimetry in healthy individuals.